{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:04:48Z","timestamp":1779779088999,"version":"3.53.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473809"],"award-info":[{"award-number":["82473809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22137008"],"award-info":[{"award-number":["22137008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Reserve Talents of Young and Middle-aged Academic and Technical Leaders in Yunnan Province","award":["202105AC160021"],"award-info":[{"award-number":["202105AC160021"]}]},{"name":"Xingdian Yingcai Project","award":["YNWR-KJLJ-2019-002"],"award-info":[{"award-number":["YNWR-KJLJ-2019-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00044-026-03558-x","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:51:30Z","timestamp":1776318690000},"page":"986-1001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis and antihepatoma activity of dimeric 1-O-acetylbritannilactone derivatives"],"prefix":"10.1007","volume":"35","author":[{"given":"Guang-Xuan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Xiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Bao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Cui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Ze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"3558_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","volume":"10","author":"C Gan","year":"2025","unstructured":"Gan C, Yuan Y, Shen HY, Gao JH, Kong XX, Che ZD, et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther. 2025;10:33 https:\/\/doi.org\/10.1038\/s41392-024-02072-z.","journal-title":"Signal Transduct Target Ther"},{"key":"3558_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113690","volume":"224","author":"SL Man","year":"2021","unstructured":"Man SL, Luo C, Yan MY, Zhao GG, Ma L, Gao WY. Treatment for liver cancer: from sorafenib to natural products. Eur J Med Chem. 2021;224:113690. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113690.","journal-title":"Eur J Med Chem"},{"key":"3558_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017.","journal-title":"J Hepatol"},{"key":"3558_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01\/1981\u201309\/2019. J Nat Prod. 2020;83:770\u2013803. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01285.","journal-title":"J Nat Prod"},{"key":"3558_CR5","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.1021\/jm301064b","volume":"55","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Lu YX, Ding YH, Zhai JD, Ji Q, Ma WW, et al. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem. 2012;55:8757\u201369. https:\/\/doi.org\/10.1021\/jm301064b.","journal-title":"J Med Chem"},{"key":"3558_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111706","volume":"183","author":"YH Ding","year":"2019","unstructured":"Ding YH, Li SZ, Ge WZ, Liu ZQ, Zhang XH, Wang MM, et al. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma. Eur J Med Chem. 2019;183:111706. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111706.","journal-title":"Eur J Med Chem"},{"key":"3558_CR7","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3390\/molecules28083389","volume":"28","author":"P Zhao","year":"2023","unstructured":"Zhao P, Song H, Gao FT, Chen L, Qiu JF, Jin J, et al. A novel derivative of curcumol, HCL-23, Inhibits the malignant phenotype of triple-negative breast cancer and induces apoptosis and HO-1-dependent ferroptosis. Molecules. 2023;28:3389 https:\/\/doi.org\/10.3390\/molecules28083389.","journal-title":"Molecules"},{"key":"3558_CR8","doi-asserted-by":"publisher","first-page":"e0148968","DOI":"10.1371\/journal.pone.0148968","volume":"11","author":"JS Zhao","year":"2016","unstructured":"Zhao JS, Niu HL, Li AY, Nie L. Acetylbritannilactone modulates vascular endothelial growth factor signaling and regulates angiogenesis in endothelial cells. PLoS One. 2016;11:e0148968 https:\/\/doi.org\/10.1371\/journal.pone.0148968.","journal-title":"PLoS One"},{"key":"3558_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF02980051","volume":"27","author":"KH Je","year":"2004","unstructured":"Je KH, Han AR, Lee HT, Mar W, Seo EK. The inhibitory principle of lipopolysaccharide-induced nitric oxide production from Inula britannica var. chinensis. Arch Pharm Res. 2004;27:83\u201385. https:\/\/doi.org\/10.1007\/BF02980051.","journal-title":"Arch Pharm Res"},{"key":"3558_CR10","first-page":"313","volume":"25","author":"MM Rafi","year":"2005","unstructured":"Rafi MM, Bai NS, Ho CT, Rosen RT, White E, Perez D, et al. A sesquiterpenelactone from Inula britannica induces anti-tumor effects dependent on Bcl-2 phosphorylation. Anticancer Res. 2005;25:313\u20138.","journal-title":"Anticancer Res"},{"key":"3558_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3892\/or.2011.1411","volume":"26","author":"XM Fang","year":"2011","unstructured":"Fang XM, Liu B, Liu YB, Wang JJ, Wen JK, Li BH, et al. Acetylbritannilactone suppresses growth via upregulation of kr\u00fcppel-like transcription factor 4 expression in HT-29 colorectal cancer cells. Oncol Rep. 2011;26:1181\u20137. https:\/\/doi.org\/10.3892\/or.2011.1411.","journal-title":"Oncol Rep"},{"key":"3558_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1124\/jpet.107.127407","volume":"324","author":"B Liu","year":"2008","unstructured":"Liu B, Han M, Wen JK. Acetylbritannilactone inhibits neointimal hyperplasia after balloon injury of rat artery by suppressing nuclear factor-{kappa}B activation. J Pharmacol Exp Ther. 2008;324:292\u20138. https:\/\/doi.org\/10.1124\/jpet.107.127407.","journal-title":"J Pharmacol Exp Ther"},{"key":"3558_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.lfs.2003.12.022","volume":"75","author":"M Han","year":"2004","unstructured":"Han M, Wen JK, Zheng B, Zhang DQ. Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci. 2004;75:675\u201384. https:\/\/doi.org\/10.1016\/j.lfs.2003.12.022.","journal-title":"Life Sci"},{"key":"3558_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejmech.2014.04.028","volume":"80","author":"S Dong","year":"2014","unstructured":"Dong S, Tang JJ, Zhang CC, Tian JM, Guo JT, Zhang Q, et al. Semisynthesis and in vitro cytotoxic evaluation of new analogues of 1-O-acetylbritannilactone, a sesquiterpene from Inula britannica. Eur J Med Chem. 2014;80:71\u201382. https:\/\/doi.org\/10.1016\/j.ejmech.2014.04.028.","journal-title":"Eur J Med Chem"},{"key":"3558_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mnfr.200600148","volume":"51","author":"MH Pan","year":"2007","unstructured":"Pan MH, Chiou YS, Cheng AC, Bai NS, Lo CY, Tan D, et al. Involvement of MAPK, Bcl-2 family, cytochrome c, and caspases in induction of apoptosis by 1,6-O,O-diacetylbritannilactone in human leukemia cells. Mol Nutr Food Res. 2007;51:229\u201338. https:\/\/doi.org\/10.1002\/mnfr.200600148.","journal-title":"Mol Nutr Food Res"},{"key":"3558_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.phymed.2008.08.003","volume":"16","author":"YP Liu","year":"2009","unstructured":"Liu YP, Wen JK, Wu YB, Zhang J, Zheng B, Zhang DQ, et al. 1,6-O,O-diacetylbritannilactones inhibits IkappaB kinase beta-dependent NF-kappaB activation. Phytomedicine. 2009;16:156\u201360. https:\/\/doi.org\/10.1016\/j.phymed.2008.08.003.","journal-title":"Phytomedicine"},{"key":"3558_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbrc.2015.06.126","volume":"464","author":"ZF He","year":"2015","unstructured":"He ZF, Zhang H, Miao HW, Li ZJ, Zhou JJ, Yan XY, et al. 1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling. Biochem Biophys Res Commun. 2015;464:422\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.126.","journal-title":"Biochem Biophys Res Commun"},{"key":"3558_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.64","volume":"2","author":"B Liu","year":"2011","unstructured":"Liu B, Wen JK, Li BH, Fang XM, Wang JJ, Zhang YP, et al. Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms. Cell Death Dis. 2011;2:e185. https:\/\/doi.org\/10.1038\/cddis.2011.64.","journal-title":"Cell Death Dis"},{"key":"3558_CR19","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.bmc.2005.02.024","volume":"13","author":"SX Liu","year":"2005","unstructured":"Liu SX, Liu H, Yan WY, Zhang L, Bai NS, Ho CT. Design, synthesis, and anti-tumor activity of (2-O-alkyloxime-3-phenyl)-propionyl-1-O-acetylbritannilactone esters. Bioorg Med Chem. 2005;13:2783\u20139. https:\/\/doi.org\/10.1016\/j.bmc.2005.02.024.","journal-title":"Bioorg Med Chem"},{"key":"3558_CR20","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.apsb.2020.12.006","volume":"11","author":"LH Su","year":"2021","unstructured":"Su LH, Zhang XT, Ma YB, Geng CA, Huang XY, Hu J, et al. New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity. Acta Pharm Sin B. 2021;11:1648\u201366. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.006.","journal-title":"Acta Pharm Sin B"},{"key":"3558_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-022-01267-6","volume":"8","author":"XF He","year":"2023","unstructured":"He XF, Ma WJ, Hu J, Li TZ, Geng CA, Ma YB, et al. Diverse structures and antihepatoma effect of sesquiterpenoid dimers from Artemisia eriopoda by AKT\/STAT signaling pathway. Signal Transduct Target Ther. 2023;8:64 https:\/\/doi.org\/10.1038\/s41392-022-01267-6.","journal-title":"Signal Transduct Target Ther"},{"key":"3558_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118412","volume":"303","author":"TZ Li","year":"2026","unstructured":"Li TZ, Li FJ, Hu MM, Huang FD, Ma YB, Yang Y, et al. Synthesis and discovery of guaianolide - eudesmanolide heterodimers as CDK2 inhibitors for the treatment of hepatocellular carcinoma. Eur J Med Chem. 2026;303:118412. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118412.","journal-title":"Eur J Med Chem"},{"key":"3558_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118160","volume":"300","author":"TZ Li","year":"2025","unstructured":"Li TZ, Huang FD, Yan JX, Hu MM, Li FJ, Ma YB, et al. Discovery of dimeric guaianolides with all carbon linkers as potential antihepatoma agents. Eur J Med Chem. 2025;300:118160. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118160.","journal-title":"Eur J Med Chem"},{"key":"3558_CR24","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00044-022-02890-2","volume":"31","author":"JJ Sun","year":"2022","unstructured":"Sun JJ, Wang JP, Li TZ, Ma YB, Xue D, Chen JJ. Design and synthesis of ludartin derivatives as potential anticancer agents against hepatocellular carcinoma. Med Chem Res. 2022;31:1224\u201339. https:\/\/doi.org\/10.1007\/s00044-022-02890-2.","journal-title":"Med Chem Res"},{"key":"3558_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejmech.2016.02.039","volume":"115","author":"AK El-Damasy","year":"2016","unstructured":"El-Damasy AK, Lee JH, Seo SH, Cho NC, Pae AN, Keum G. Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities. Eur J Med Chem. 2016;115:201\u201316. https:\/\/doi.org\/10.1016\/j.ejmech.2016.02.039.","journal-title":"Eur J Med Chem"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03558-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03558-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03558-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:48:57Z","timestamp":1779778137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03558-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3558"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03558-x","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}